Genoa Pharmaceuticals competitorsClear all

Genoa Pharmaceuticals's top competitors include Ventria Bioscience, Retrophin, Palatin Technologies and Melinta Therapeutics.
Genoa Pharmaceuticals
Genoa Pharmaceuticals
Genoa Pharmaceuticals develops therapies for the treatment of idiopathic pulmonary fibrosis.
Ventria Bioscience
Ventria Bioscience
Ventria Bioscience develops life-saving medicines targeting inflammatory, infectious and gastrointestinal diseases.
Retrophin
Retrophin
Retrophin is a biopharmaceutical company which focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
Palatin Technologies
Palatin Technologies
Palatin Technologies is a biopharmaceutical company, developing targeted, receptor-specific peptide therapeutics for the treatment of various diseases.
Melinta Therapeutics
Melinta Therapeutics
Melinta Therapeutics is an antibiotics-focused company that develops and commercializes antibiotics to overcome drug-resistant infections.
Founding Date
Founding Date
2011
Founding Date
1993
Founding Date
2011
Founding Date
1986
Founding Date
2000
Type
Type
Private
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Seattle, US HQ
Locations
Junction City, US HQ
Aurora, US
Locations
San Diego, US HQ
Dublin, IE
New York, US
Cambridge, US
Locations
Cranbury, US HQ
Locations
HQ
New Haven, US
Employees
Employees
233% decrease
Employees
31
Employees
21424% increase
Employees
1914% decrease
Employees
2612% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
795.6 m
Valuation ($)
262 m
Valuation ($)
24.6 m
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
2
Twitter followers
507
Twitter followers
341
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
848079
Alexa Website Rank
449035
Alexa Website Rank
787008
Alexa Website Rank
814950

Financial

Net income
Net income
N/A
Net income
N/A
Net income
($102.7m) (FY, 2018)
Net income
$24.7m (FY, 2018)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 64.2m
Total funding raised
$ 7.7m
Total funding raised
$ 116m
Total funding raised
$ 104.2m
Total funding raised
$ 519.2m
For sources of this data, please see the company profile

View company profiles

Ventria Bioscience
HQ
Junction City, US
Employees
31

Ventria Bioscience develops life-saving medicines targeting inflammatory, infectious and gastrointestinal diseases.

View company
Retrophin
HQ
San Diego, US
Employees
214↑ 24% increase

Retrophin is a biopharmaceutical company which focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.

View company
Palatin Technologies
HQ
Cranbury, US
Employees
19↓ 14% decrease

Palatin Technologies is a biopharmaceutical company, developing targeted, receptor-specific peptide therapeutics for the treatment of various diseases.

View company
Melinta Therapeutics
HQ
Employees
261↓ 2% decrease

Melinta Therapeutics is an antibiotics-focused company that develops and commercializes antibiotics to overcome drug-resistant infections.

View company